|
Volumn 144, Issue 19 SUPPL., 2000, Pages
|
New pharmacologic, diagnostic options advance diabetes care
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLIBENCLAMIDE;
GLUCOSE;
GLUCOVANCE;
HEMOGLOBIN A1C;
HUMALOG MIX 75/25;
INSULIN;
INSULIN ASPART;
INSULIN GLARGINE;
INSULIN[B28 LYSINE B29 PROLINE];
ISOPHANE INSULIN;
LANTUS;
METFORMIN;
NATEGLINIDE;
NOVOLOG;
ORAL ANTIDIABETIC AGENT;
PIOGLITAZONE;
REPAGLINIDE;
ROSIGLITAZONE;
TROGLITAZONE;
UNCLASSIFIED DRUG;
ADOLESCENT;
ADULT;
BLOOD SAMPLING;
CHILD;
DIABETES CONTROL;
DIABETES MELLITUS;
DIAGNOSTIC TEST;
DRUG APPROVAL;
DRUG HYPERSENSITIVITY;
DRUG INDUCED DISEASE;
FOOD AND DRUG ADMINISTRATION;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPOGLYCEMIA;
INJECTION SITE;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN TREATMENT;
LABORATORY TEST;
LIVER TOXICITY;
MEDICAL INSTRUMENTATION;
MEDICAL TECHNOLOGY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT MONITORING;
PHARMACIST;
REVIEW;
SIDE EFFECT;
|
EID: 0034596963
PISSN: 00126616
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (0)
|